During March, the FDA inspected six biologics companies across Pennsylvania, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the second-largest share of FDA visits by company type in Pennsylvania, accounting for 20.7% of all inspections conducted that month.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 5 | — | — |
| Compliance: Devices | 1 | 3 | — |
| Drug Quality Assurance | 1 | — | — |
| Food Composition, Standards, Labeling and Econ | 5 | — | — |
| Foodborne Biological Hazards | 13 | 3 | — |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
| Postmarket Assurance: Devices | 1 | 1 | — |
| Technical Assistance: Food and Cosmetics | 2 | — | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
